Endocrinology, Vol 136, 1595-1602, Copyright © 1995 by Endocrine Society

ARTICLES

Corticotropin-releasing hormone and epidermal growth factor: mitogens for anterior pituitary corticotropes

GV Childs, D Rougeau and G Unabia
Department of Anatomy and Neurosciences, University of Texas Medical Branch, Galveston 77555-1043.

Anterior pituitary corticotropes increase in number after stimulation by adrenalectomy or corticotropin-releasing hormone (CRH). However, is this brought about by mitoses? Furthermore, as epidermal growth factor (EGF) is a potent secretagogue for corticotropes, is it also a mitogen? To address these questions, populations of corticotropes enriched to 88- 97% by counterflow centrifugation were studied after growth in 0-10 nM CRH with and without 0.1-10 ng/ml EGF. Three types of assays were used to detect changes in mitotic cells or cell number. An enzyme immunoassay for bromodeoxyuridine uptake during DNA synthesis [bromodeoxyuridine (BrDU) uptake] detected a 3-fold increase in optical density readings in the presence of 0.5 nM CRH or EGF. Together the peptides increased the optical density to 4.8-fold basal levels. No further increases in BrDU uptake were seen with higher concentrations of CRH or EGF. Cytochemical detection of BrDU uptake by immunolabeled corticotropes showed BrDU in 18 +/- 2% of 3- to 5-day ACTH cells. In the presence of 0.5 nM CRH or 0.5 ng/ml EGF, this value increased to 37 +/- 3% or 34 +/- 2% of ACTH cells, respectively. Together CRH and EGF stimulated increases in mitotic activity so that 47 +/- 4% of the ACTH cells were labeled for BrDU after a 1-h exposure. Cell growth/cell death assays in 3-(4,5-dimethyltiazol-2-yl)2,5- diphenyl tetrazolium bromide were also used to detect changes in overall cell number or cell survival in the same groups of enriched corticotrope cultures. Both 0.5 nM CRH and 0.5 ng/ml EGF caused increases to 1.5- to 1.7-fold basal readings. However, higher concentrations did not stimulate increases in number, and their combined effects were not additive. These studies show that CRH and EGF can be mitogens for ACTH-bearing corticotropes, in a limited dose range. In a higher dose range, their differentiating effects may eliminate dividing cells and retard further growth of the population.

This article has been cited by other articles:

				T.-W. Noh, H. J. Jeong, M.-K. Lee, T. S. Kim, S. H. Kim, and E. J. Lee Predicting Recurrence of Nonfunctioning Pituitary Adenomas J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4406 - 4413. [Abstract] [Full Text] [PDF]

				N. Ben-Jonathan, S. Chen, J. A. Dunckley, C. LaPensee, and S. Kansra Estrogen Receptor-{alpha} Mediates the Epidermal Growth Factor-Stimulated Prolactin Expression and Release in Lactotrophs Endocrinology, February 1, 2009; 150(2): 795 - 802. [Abstract] [Full Text] [PDF]

				G. Vlotides, E. Siegel, I. Donangelo, S. Gutman, S.-G. Ren, and S. Melmed Rat Prolactinoma Cell Growth Regulation by Epidermal Growth Factor Receptor Ligands Cancer Res., August 1, 2008; 68(15): 6377 - 6386. [Abstract] [Full Text] [PDF]

				C. Crane, N. Akhter, B. W. Johnson, M. Iruthayanathan, F. Syed, A. Kudo, Y.-H. Zhou, and G. V. Childs Fasting and Glucose Effects on Pituitary Leptin Expression: Is Leptin a Local Signal for Nutrient Status? J. Histochem. Cytochem., October 1, 2007; 55(10): 1059 - 1073. [Abstract] [Full Text] [PDF]

				G. Vlotides, M. Cruz-Soto, T. Rubinek, T. Eigler, C. J. Auernhammer, and S. Melmed Mechanisms for Growth Factor-Induced Pituitary Tumor Transforming Gene-1 Expression in Pituitary Folliculostellate TtT/GF Cells Mol. Endocrinol., December 1, 2006; 20(12): 3321 - 3335. [Abstract] [Full Text] [PDF]

				E. Theogaraj, C. D. John, H. C. Christian, J. F. Morris, S. F. Smith, and J. C. Buckingham Perinatal Glucocorticoid Treatment Produces Molecular, Functional, and Morphological Changes in the Anterior Pituitary Gland of the Adult Male Rat Endocrinology, November 1, 2005; 146(11): 4804 - 4813. [Abstract] [Full Text] [PDF]

				M Theodoropoulou, T Arzberger, Y Gruebler, M L Jaffrain-Rea, J Schlegel, L Schaaf, E Petrangeli, M Losa, G K Stalla, and U Pagotto Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells J. Endocrinol., November 1, 2004; 183(2): 385 - 394. [Abstract] [Full Text] [PDF]

				G. V. Childs and G. Unabia Epidermal Growth Factor and Gonadotropin-Releasing Hormone Stimulate Proliferation of Enriched Population of Gonadotropes Endocrinology, February 1, 2001; 142(2): 847 - 853. [Abstract] [Full Text] [PDF]

				R. Ramesh, W.J. Kuenzel, and J.A. Proudman Increased Proliferative Activity and Programmed Cellular Death in the Turkey Hen Pituitary Gland Following Interruption of Incubation Behavior Biol Reprod, February 1, 2001; 64(2): 611 - 618. [Abstract] [Full Text]

				R. Sosnowski, P. L. Mellon, and M. A. Lawson Activation of Translation in Pituitary Gonadotrope Cells by Gonadotropin-Releasing Hormone Mol. Endocrinol., November 1, 2000; 14(11): 1811 - 1819. [Abstract] [Full Text]

				J. Schwartz Intercellular Communication in the Anterior Pituitary Endocr. Rev., October 1, 2000; 21(5): 488 - 513. [Abstract] [Full Text]

				P. L. M. Dahia and A. B. Grossman The Molecular Pathogenesis of Corticotroph Tumors Endocr. Rev., April 1, 1999; 20(2): 136 - 155. [Abstract] [Full Text]

				U. Pagotto, T. Arzberger, E. Ciani, F. Lezoualc’h, C. Pilon, L. Journot, D. Spengler, and G. K. Stalla Inhibition of Zac1, a New Gene Differentially Expressed in the Anterior Pituitary, Increases Cell Proliferation Endocrinology, February 1, 1999; 140(2): 987 - 996. [Abstract] [Full Text]

				S. L. Asa and S. Ezzat The Cytogenesis and Pathogenesis of Pituitary Adenomas Endocr. Rev., December 1, 1998; 19(6): 798 - 827. [Abstract] [Full Text]

				J. L. Armstrong and G. V. Childs Regulation of c-fos Expression by EGF and GnRH in Specific Anterior Pituitary Cells from Proestrous Female Rats J. Histochem. Cytochem., August 1, 1998; 46(8): 935 - 944. [Abstract] [Full Text]

				M. Venihaki, K. Ain, E. Dermitzaki, A. Gravanis, and A. N. Margioris KAT45, a Noradrenergic Human Pheochromocytoma Cell Line Producing Corticotropin-Releasing Hormone Endocrinology, February 1, 1998; 139(2): 713 - 722. [Abstract] [Full Text] [PDF]

				D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text]